Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Waleed Abdelall, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, Keyur P. Patel, MD PhD, Elias J. Jabbour, MD, Naval G. Daver, MD, Tapan Kadia, MD, Rosilyn A. Gborogen, RN, Marina Konopleva, MD PhD, Farhad Ravandi, MD, Michael Andreef, MD PhD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 1642.

https://doi.org/10.1182/blood.V128.22.1642.1642

Published: 2016

Journal Articles

Additional Chromosomal Abnormalities in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Tyrosine Kinase Inhibitors: Differential Outcomes According to Type of Chromosomal Abnormality

Nicholas J. Short, MD, Elias J. Jabbour, MD, Koji Sasaki, MD, Heidi Ko, MD, Farhad Ravandi, MD, C. Cameron Yin, MD PhD, Maria R. Khouri, Jorge E. Cortes, MD, Rebecca Garris, MS, Susan M. O'Brien, MD, Keyur P. Patel, MD PhD, Guillermo Garcia-Manero, MD, Deborah A Thomas, MD, Naval Daver, MD, Kiran Naqvi, MD, Prithviraj Bose, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Hagop M. Kantarjian, MD

Blood (2016) 128 (22): 1737.

https://doi.org/10.1182/blood.V128.22.1737.1737

Published: 2016

Journal Articles

Factors Affecting Survival Outcomes in Patients with Blast Phase CML (CML-BP) in the Tyrosine Kinase Inhibitor (TKI) Era: A Cohort Study of 498 Patients

Blood (2016) 128 (22): 1220.

https://doi.org/10.1182/blood.V128.22.1220.1220

Published: 2016

Journal Articles

Routine Clinical Testing for Actionable Mutations in CLL Using Endcll Assay V1: The Initial MD Anderson Experience

Keyur P. Patel, MD PhD, Rajesh Singh, PhD, Mark Routbort, MD PhD, C. Cameron Yin, MD PhD, Rashmi Kanagal Shamanna, PhD, Nitin Jain, MD, Xinyan Lu, MD, Sherry Pierce, BSN, BA, Michael Keating, MBBS, Hagop M. Kantarjian, MD, L. Jeffrey Medeiros, MD, Raja Luthra, PhD, William G. Wierda, MD PhD

Blood (2016) 128 (22): 3196.

https://doi.org/10.1182/blood.V128.22.3196.3196

Published: 2016

Journal Articles

Clonal Hematopoiesis Increases Risk of Therapy-Related Myeloid Neoplasms

Koichi Takahashi, MD, Feng Wang, PhD, Hagop M. Kantarjian, MD, Doss Denaha, Kanhav Khann, MS, Keyur P. Patel, MD PhD, Sattva S. Neelapu, MD, Curtis Gumbs, Carlos E Bueso-Ramos, MD PhD, Courtney D. DiNardo, MD MSCE, Simona Colla, PhD, Farhad Ravandi, MD, Jianhua Zhang, Xifeng Wu, Felipe Samaniego, MD, Guillermo Garcia-Manero, MD, Andrew Futreal, PhD

Blood (2016) 128 (22): 38.

https://doi.org/10.1182/blood.V128.22.38.38

Published: 2016

Journal Articles

Validation of the 2016 Revision to the World Health Organization (WHO) Classification of Myelodysplastic Syndromes with Diploid Karyotype

Rashmi Kanagal-Shamanna, MD, Juliana E. Hidalgo Lopez, MD, Hye Ryoun Kim, MD PhD, Zhuang Zuo, MD PhD, Michelle Janania Martinez, Chong Zhao, MD PhD MS, Denái R. Milton, Francesco Stingo, PhD, John Lee, MD PhD, Raja Luthra, PhD, Keyur P. Patel, MD PhD, Elias J. Jabbour, MD, Guillermo Garcia-Manero, MD, L. Jeffrey Medeiros, MD, Carlos E Bueso-Ramos, MD PhD

Blood (2016) 128 (22): 4319.

https://doi.org/10.1182/blood.V128.22.4319.4319

Published: 2016

Journal Articles

Clinical Implementation of a Testing Algorithm for the Diagnosis of Ph-like B-Cell Acute Lymphoblastic Leukemia

Xinyan Lu, MD, Alexandra Reynolds, Sergej Konopleva, MD, Sa Wang, MD, Kathryn G. Roberts, PhD, Charles Mullighan, MBBS, MSc, MD, Guilin Tang, MD, Zhenya Tang, MD, Patrick Zweidler-McKay, MD PhD, Jeffrey L. Jorgensen, MD PhD, Keyur P. Patel, MD PhD, L. Jeffrey Medeiros, MD, Pei Lin, MD, Marina Konopleva, MD PhD, Nitin Jain, MD

Blood (2016) 128 (22): 2915.

https://doi.org/10.1182/blood.V128.22.2915.2915

Published: 2016

Journal Articles

Clinical Implications of TP53 Mutations in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Treated with the Hypercvad-Based Regimens

Blood (2016) 128 (22): 2917.

https://doi.org/10.1182/blood.V128.22.2917.2917

Published: 2016

Journal Articles

Clinical Characteristics of Philadelphia Positive T-Cell Lymphoid Leukemias - (de novo and blast phase CML)

Preetesh Jain, MBBS, MDDM, PhD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Rashmi Kanagal-Shamanna, MD, Keyur P. Patel, MD PhD, Sara Emogene DellaSala, BS, Sherry Pierce, BSN, BA, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Susan M. O'Brien, MD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 5436.

https://doi.org/10.1182/blood.V128.22.5436.5436

Published: 2016

Journal Articles

Discovery of Predictive Gene Signatures for Tumor Sensitivity to MDM2 Inhibition in Development of a Novel MDM2 Inhibitor DS-3032b

Jo Ishizawa, MD PhD, Kenji Nakamaru, Takahiko Seki, Koichi Tazaki, Kensuke Kojima, MD PhD, Dhruv Chachad, Courtney D DiNardo, MD, Sherry Pierce, BSN, BA, Keyur P. Patel, MD PhD, Archie Tse, R Eric Davis, MD, Arvind Rao, PhD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 2893.

https://doi.org/10.1182/blood.V128.22.2893.2893

Published: 2016

Journal Articles

Pure Erythroid Leukemia Is Characterized By TP53mutations, a Complex Karyotype with Chromosome 17 Abnormalities, and Adverse Risk Independent of Therapy Type

Guillermo Montalban-Bravo, MD, Christopher B. Benton, MD, Sa A. Wang, MD, Farhad Ravandi, MD, Tapan M. Kadia, MD, Jorge E. Cortes, MD, Naval Daver, MD, Koichi Takahashi, MD, Courtney D DiNardo, MD, Elias J. Jabbour, MD, Gautam Borthakur, MD, Marina Konopleva, MD PhD, Sherry Pierce, BSN, BA, Keyur P. Patel, MD PhD, Steven M Kornblau, PhD, Hagop M. Kantarjian, MD, Ken H. Young, MD PhD, Guillermo Garcia-Manero, MD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 2852.

https://doi.org/10.1182/blood.V128.22.2852.2852

Published: 2016

Journal Articles

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL) with Hypercvad Based Regimens

Preetesh Jain, MBBS, MDDM, PhD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Rashmi Kanagal-Shamanna, MD, Joseph D Khoury, MD, Keyur P. Patel, MD PhD, Guillermo Garcia-Manero, MD, Marina Konopleva, MD PhD, Nitin Jain, MD, Koji Sasaki, MD, Tapan M. Kadia, MD, Gautam Borthakur, MD, Rebecca Garris, Sherry Pierce, BSN, BA, Zeev Estrov, MD, William G. Wierda, MD PhD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Elias J. Jabbour, MD

Blood (2016) 128 (22): 2779.

https://doi.org/10.1182/blood.V128.22.2779.2779

Published: 2016

Journal Articles

Patterns of Relapse in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Who Achieve Complete Molecular Response with Chemotherapy Plus a Tyrosine Kinase Inhibitor

Nicholas J. Short, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Rebecca Garris, MS, Susan M. O'Brien, MD, Keyur P. Patel, MD PhD, Jeffrey L. Jorgensen, MD PhD, Joseph D Khoury, MD, Guillermo Garcia-Manero, MD, Deborah A Thomas, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD

Blood (2016) 128 (22): 3977.

https://doi.org/10.1182/blood.V128.22.3977.3977

Published: 2016

Journal Articles

Aleukemic Mast Cell Leukemia (aMCL) - Clinical Characteristics and Outcomes

Preetesh Jain, MBBS, MDDM, PhD, Sa Wang, MD, Hagop M. Kantarjian, MD, Nawid Sarwari, Keyur P. Patel, MD PhD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Tapan M. Kadia, MD, Naval Daver, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Srdan Verstovsek, MD PhD

Blood (2016) 128 (22): 4255.

https://doi.org/10.1182/blood.V128.22.4255.4255

Published: 2016

Journal Articles

Mutation Analysis in 200 Cases of Newly Diagnosed Myelodysplastic Syndrome By Next Generation Sequencing: Association with Established Prognostic Variables and IPSS-R

Kankana Ghosh, B. Pharm, Parsa Hodjat, MD, Priyanka Priyanka, MPH, Beenu Thakral, MBBS,MD, Keyur P. Patel, MD PhD, Mark Routbort, MD PhD, Rashmi Kanagal-Shamana, MD, C. Cameron Yin, MDPhD, Zhuang Zuo, MD PhD, Raja Luthra, PhD, Tariq Muzzafar, MD

Blood (2015) 126 (23): 1703.

https://doi.org/10.1182/blood.V126.23.1703.1703

Published: 2015

Journal Articles

RAS/RAF Pathway Mutations Define a Distinct Subset of Chronic Lymphocytic Leukemia

Rashmi Kanagal-Shamanna, MD, Raja Luthra, PhD, Madan Luthra, PhD, Xinyan Lu, MD, Mark Routbort, MD PhD, Nitin Jain, MD, Michael Keating, MBBS, L Jeffrey Medeiros, MD, William Wierda, MD PhD, Keyur P. Patel, MD PhD

Blood (2015) 126 (23): 1730.

https://doi.org/10.1182/blood.V126.23.1730.1730

Published: 2015

Journal Articles

Efficacy and Safety of Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia and Polycythemia Vera: Results after a Median 7-Year Follow-up of a Phase 2 Study

Lucia Masarova, MD, Srdan Verstovsek, MD, Keyur P. Patel, MD PhD, Kate J Newberry, PhD, Jorge E. Cortes, MD, Gautam Borthakur, MD, Marina Konopleva, MD PhD, Zeev Estrov, MD, Hagop M. Kantarjian, MD

Blood (2015) 126 (23): 60.

https://doi.org/10.1182/blood.V126.23.60.60

Published: 2015

Journal Articles

Clinical and Molecular Characterization of p53-Mutated Acute Myeloid Leukemia

Tapan Kadia, MD, Jorge E. Cortes, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Michael Andreeff, MD PhD, Koichi Takahashi, MD, Gautam Borthakur, MD, Elias J. Jabbour, MD, Kapil N. Bhalla, MD, Marina Konopleva, MD PhD, Naval Daver, MD, Courtney DiNardo, MD, Prithviraj Bose, MD, Keyur P. Patel, MD PhD, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD

Blood (2015) 126 (23): 564.

https://doi.org/10.1182/blood.V126.23.564.564

Published: 2015

Journal Articles

Impact of the Type of BCR-ABL Fusion Transcripts on Response and Survival in Patients with Chronic Phase CML Treated with Four Frontline TKI Modalities

Preetesh Jain, MBBS,MDDM,PhD, Hagop M. Kantarjian, MD, Raja Luthra, PhD, Graciela Nogueras Gonzalez, Elias Jabbour, Koji Sasaki, MD, Carlos Guillermo Romo, MD, Keyur P. Patel, MD PhD, Tapan Kadia, MD, Gautam Borthakur, MD, Zeev Estrov, MD, Farhad Ravandi, MD, Susan O'Brien, MD, Jorge E. Cortes, MD

Blood (2015) 126 (23): 598.

https://doi.org/10.1182/blood.V126.23.598.598

Published: 2015

Journal Articles

Mutation Analysis in 276 Cases of Newly Diagnosed Acute Myeloid Leukemia By Next Generation Sequencing: Association with Established Prognostic Variables and MRC Risk Groups

Parsa Hodjat, MD, Kankana Ghosh, B. Pharm, Priyanka Priyanka, MPH, Beenu Thakral, MBBS,MD, Keyur P. Patel, MD PhD, Mark Routbort, MD PhD, Rashmi Kanagal-Shamana, MD, C. Cameron Yin, MDPhD, Zhuang Zuo, MD PhD, Raja Luthra, PhD, Tariq Muzzafar, MD

Blood (2015) 126 (23): 1392.

https://doi.org/10.1182/blood.V126.23.1392.1392

Published: 2015

NARROW

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Additional Chromosomal Abnormalities in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Tyrosine Kinase Inhibitors: Differential Outcomes According to Type of Chromosomal Abnormality

Factors Affecting Survival Outcomes in Patients with Blast Phase CML (CML-BP) in the Tyrosine Kinase Inhibitor (TKI) Era: A Cohort Study of 498 Patients

Routine Clinical Testing for Actionable Mutations in CLL Using Endcll Assay V1: The Initial MD Anderson Experience

Clonal Hematopoiesis Increases Risk of Therapy-Related Myeloid Neoplasms

Validation of the 2016 Revision to the World Health Organization (WHO) Classification of Myelodysplastic Syndromes with Diploid Karyotype

Clinical Implementation of a Testing Algorithm for the Diagnosis of Ph-like B-Cell Acute Lymphoblastic Leukemia

Clinical Implications of TP53 Mutations in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Treated with the Hypercvad-Based Regimens

Clinical Characteristics of Philadelphia Positive T-Cell Lymphoid Leukemias - (de novo and blast phase CML)

Discovery of Predictive Gene Signatures for Tumor Sensitivity to MDM2 Inhibition in Development of a Novel MDM2 Inhibitor DS-3032b

Pure Erythroid Leukemia Is Characterized By TP53mutations, a Complex Karyotype with Chromosome 17 Abnormalities, and Adverse Risk Independent of Therapy Type

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL) with Hypercvad Based Regimens

Patterns of Relapse in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Who Achieve Complete Molecular Response with Chemotherapy Plus a Tyrosine Kinase Inhibitor

Aleukemic Mast Cell Leukemia (aMCL) - Clinical Characteristics and Outcomes

Mutation Analysis in 200 Cases of Newly Diagnosed Myelodysplastic Syndrome By Next Generation Sequencing: Association with Established Prognostic Variables and IPSS-R

RAS/RAF Pathway Mutations Define a Distinct Subset of Chronic Lymphocytic Leukemia

Efficacy and Safety of Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia and Polycythemia Vera: Results after a Median 7-Year Follow-up of a Phase 2 Study

Clinical and Molecular Characterization of p53-Mutated Acute Myeloid Leukemia

Impact of the Type of BCR-ABL Fusion Transcripts on Response and Survival in Patients with Chronic Phase CML Treated with Four Frontline TKI Modalities

Mutation Analysis in 276 Cases of Newly Diagnosed Acute Myeloid Leukemia By Next Generation Sequencing: Association with Established Prognostic Variables and MRC Risk Groups

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only